











1Scientific Laboratory of Molecular Genetics, Riga Stradiņš University, Riga, Latvia
2Institute of Oncology, Riga Stradiņš University, Riga, Latvia
3 Department of Hematology and Oncology, Children’s Clinical University Hospital, 
Riga, Latvia
4Latvian Biomedical Research and Study Centre, Riga, Latvia
Submitted: 2 October 2014
Accepted: 10 November 2014
Arch Med Sci 2016; 12, 3: 479–485
DOI: 10.5114/aoms.2016.59920
Copyright © 2016 Termedia & Banach
Analysis of possible genetic risk factors contributing 
to development of childhood acute lymphoblastic 
leukaemia in the Latvian population 
Madara Kreile1,2, Linda Piekuse1, Dmitrijs Rots1, Zane Dobele1, Zhanna Kovalova3, Baiba Lace4
A b s t r a c t
Introduction: Childhood acute lymphoblastic leukaemia (ALL) is a  complex 
disease caused by a combination of genetic susceptibility and environmental 
exposure. Previous genome-wide association studies have reported several 
single nucleotide polymorphisms (SNPs) associated with the incidence of ALL. 
Several variations in genes encoding enzymes involved in carcinogenesis are 
suggested as being associated with an increased risk of ALL development.
Material and methods: We enrolled 77 paediatric ALL patients and 122 
healthy controls, and in addition parental DNA was also available for 45 pro-
bands. SNPs rs10821936 (ARID5B), rs4132601 (IKZF1), rs2239633 (CEBPE), 
rs3731217 (CDKN2A) and rs1800566 (NQO1) and the presence of GSTT1 
and GSTM1 null variants were detected. For statistical analysis the hybrid 
method of two designs ‘Haplin’ was used as well as linkage disequilibrium 
for family-based association studies.
Results: We identified the SNP rs10821936 in the ARID5B gene as being 
statistically significantly associated with childhood ALL, especially if the 
C allele is in a homozygous state, relative risk (RR) 4.65, 95% CI: 2.03–10.6, 
p = 0.0006. Statistically significant differences were not found in other 
SNPs. We found risk combinations including all five variations, the strongest 
association being found in a combination where all five genetic variants are 
in a homozygous state, CCTTTTTTCC, p = 0.032.
Conclusions: The identified SNP rs10821936 could serve as a potential risk 
marker for childhood ALL development. Further studies in an independent 
population are needed for verification.
Key words: childhood acute lymphoblastic leukaemia, single nucleotide 
polymorphisms, ARID5B, IKZF1.
Introduction
Acute lymphoblastic leukaemia (ALL) is the most frequently occurring 
haematopoietic malignancy in children worldwide [1], with cure rates 
increasing from less than 10% in the 1960s to over 80% nowadays [2]. 
Acute lymphoblastic leukaemia is a  heterogeneous group of disorders 
that arise from the clonal proliferation of malignant, lymphoid cells in 
bone marrow, blood and other organs [3]. Approximately 75% of child-
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hood ALL cases harbour a recurring chromosomal 
alteration detectable by karyotyping, fluorescent 
in situ hybridization (FISH), or molecular biology 
techniques. Although rearrangements are import-
ant in initiating events in leukemogenesis and are 
widely used in diagnosis and risk stratification 
algorithms, they are insufficient to fully explain 
leukemogenesis [4]. However, even if the genetic 
markers of ALL can be detected in utero (i.e., ETV6-
RUNX1 gene), this does not inevitably lead to ALL 
[5]. The development of childhood B-cell lineage 
ALL involves (at least) 2 genetic events (hits), the 
first of which frequently arises prenatally [6]. The 
development of leukaemia might be explained by 
a combination of genetic susceptibility and envi-
ronmental exposure during early development in 
fetal life and infancy [7].
The heritable basis of susceptibility to ALL is 
further supported by recent candidate gene and 
genome-wide association studies (GWAS), sug-
gesting that co-inheritance of multiple germline 
variants may contribute to the risk of the disease. 
Five GWAS have been performed with populations 
of 3 275 ALL cases and 4 817 healthy control in-
dividuals [8]. Four independent loci have been 
shown conclusively to be associated with ALL, and 
more specifically the B-cell precursor (BCP) ALL 
risk was associated with the particular SNPs lo-
cated in 7p12.2 (IKZF1), 9p12 (CDKN2A/CDKN2B), 
10q21.2 (ARID5B) and 14q11.2 (CEBPE). While 
the risk of ALL associated with these common 
variants is not insignificant (relative risk (RR) of 
1.5–1.6), collectively they underscore 8–24% 
of the genetic variance in BCP-ALL risk [9]. The 
first GWAS performed by Trevino et al. evaluated 
307 944 germline single nucleotide polymor-
phisms (SNPs) and identified 18 SNPs whose 
allele frequency differed (p < 1 × 10–5) between 
a paediatric ALL population and non-ALL controls. 
The strongest association was shown by the SNP 
rs10821936 located within intron 3 of the ARID5B 
gene [10]. AT-rich interactive domain 5B (ARID5B) 
belongs to the ARID family of transcription factors 
and plays an important role in the regulation of 
embryonic development and cell growth and dif-
ferentiation [11]. However, the role of ARID5B in 
childhood ALL remains unknown, although alter-
ations in gene function may contribute to an in-
creased risk for this disease [12].
The second GWAS study showed that the 
IKAROS family zinc finger 1 (IKZF1) germline poly-
morphism rs4132601 is associated with inherited 
risk of paediatric ALL [13]. The product of the IKZF1 
gene is Ikaros, a  sequence-specific DNA-binding 
protein with a zinc finger motif, which plays a role 
in immune homeostasis through the transcription-
al regulation of the earliest stages of lymphocyte 
ontogeny and the differentiation by both gene 
transcriptional activation and repression [14]. 
The third association seen was at 14q11.2, with 
rs2239633 in the vicinity of CEBPE, encoding the 
CCAAT/enhancer binding protein e, a regulator of 
myelopoiesis [15]. Sherborne et al. reported an 
association between rs3731217 located in intron 
1 of the gene CDKN2A (cyclin-dependent kinase 
inhibitor 2A) and childhood ALL [16]. 
One potentially important genetic pathway, 
besides the polymorphisms detected by GWAS 
that is suspected to play a  role in the etiology 
of childhood ALL, is xenobiotic metabolism [17]. 
Polymorphisms in genes encoding xenobiotic-me-
tabolizing enzymes are largely responsible for in-
terindividual differences in the ability to activate 
and detoxify mutagenic/carcinogenic agents, and 
therefore may influence the susceptibility to can-
cer [18]. Environmental procarcinogens are acti-
vated by phase I enzymes, converting them into 
reactive intermediates, which are then detoxified 
by phase II enzymes including glutathione S trans-
ferase (GST) [19]. Functional polymorphisms have 
been reported in the genes coding GSTs; 20-50% 
of individuals do not express the enzyme GSTT1 
and/or GSTM1 due to homozygous deletion [20]. 
Individuals with the GSTT1 null and GSTM1 null 
variant are unable to eliminate carcinogens effec-
tively [21, 22]. For example, they are unable to de-
toxify tobacco-related carcinogens by conjugating 
glutathione to facilitate their removal [23], and 
can therefore be a candidate risk factor for child-
hood ALL.
The NQO1 (NAD (P) H dehydrogenase quinone 1) 
protein protects cells against quinine-induced 
oxidative stress. There have been more than 93 
polymorphisms identified, the most widely stud-
ied being NM_000903.2:c.559C>T or previously 
c.609C>T (rs1800566). Homozygosity is associ-
ated with the loss of enzyme activity due to the 
instability of the protein product [24]. The hetero-
zygous genotype showed a threefold decrease in 
enzymatic activity compared with the wild type 
allele [25]. NQO1 has been described as an anti-
cancer enzyme because it plays a protective role 
in cancerogenesis by modifying internal exposure 
to bioactivated carcinogens [26], and in the case 
of a defective enzyme it might play a role in can-
cerogenesis.
Because of the possible roles of polymor-
phisms rs10821936 (ARID5B), rs4132601 (IKZF1), 
rs2239633 (CEBPE), rs3731217 (CDKN2A) – mark-
ers which showed the strongest association from 
GWAS data – and rs1800566 (NQO1), and null 
genotypes of genes GSTT1 and GSTM1 , we per-
formed case control and case-parent triad studies 
to investigate the association between these ge-
netic markers and childhood ALL susceptibility in 
the Latvian population.
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Material and methods
Study subjects
Our cohort consisted of 76 patients with child-
hood B-cell progenitor cell ALL in complete remis-
sion, and 121 age- and gender-adjusted healthy 
controls. In addition, parental DNA was available 
for 45 probands. Out of 76 patients, 41 were male 
and 35 were female. Patients were diagnosed with 
ALL between 2005 and 2014, aged 1–18 years at 
that time. According to the data of the Latvian 
cancer patient registry, at the time of the study 
85 patients with a diagnosis of ALL were alive (8 of 
them refused to take part in this study and 1 pa-
tient was not in full remission); therefore our study 
covered 89.4% of all patients. Parents signed an in-
formed consent form, and the study was approved 
by the Central Medical Ethics committee of Latvia.
Genotyping
Peripheral blood from the patients and their 
biological parents and controls was used for DNA 
extraction. DNA isolation from white blood cells 
was performed using the standard phenol/chloro-
form method [27].
Genotyping of polymorphisms rs4132601, 
rs2239633, rs3731217, and rs1800566 was per-
formed by polymerase chain reaction – restriction 
fragment length polymorphism (PCR-RFLP) assay; 
primer sequences and restriction enzymes are 
shown in Table I. Genotype of the polymorphism 
rs10821936 was detected by Sanger sequenc-
ing; for the initial PCR we used external primers 
(F: 5’-CAGTGAGAGCGAGACTGCAC-3’; R: 5’-TCCT-
GGCAATGTTTTTCACA-3’), while for the sec-
ond amplification an internal primer was used 
(F: 5’-ACACCACCCCACATCTCAAT-3’). The direct se-
quencing of PCR products was performed using 
ABI Prism BigDye Terminator v3.1 Cycle sequenc-
ing kit (Applied Biosystems, Foster city, USA) using 
the manufacturer’s protocol.
Multiplex PCR was performed to detect the 
presence or absence of GSTT1 and GSTM1 null 
genotypes [28].
Statistical analysis
Statistical analysis using the hybrid method for 
the case-control study and case-parent study was 
performed using the R program package “Haplin” 
[29]. To analyse case-parent trios the family-based 
association test (FBAT) by the transmission distor-
tion test (TDT) and the haplotype-based TDT were 
performed, as implemented in the software PLINK 
1.07 [30]. To separately analyse the case-control 
model the software JavaStat (available online) was 
used, the Fisher exact test was used for statistical 
analysis, and a p-value < 0.05 was considered as 
statistically significant.
Results
All five analysed polymorphisms, rs10821936 
(ARID5B), rs4132601 (IKZF1), rs2239633 (CEBPE), 
rs3731217 (CDKN2A) and rs1800566 (NQO1), 
were in Hardy-Weinberg equilibrium.
Linkage and case-control studies showed a sig-
nificant association between ALL and rs10821936, 
which maps to intron 3 of the ARID5B gene. We 
did not find any significant association with 
rs4132601, which maps within the 3’ UTR region 
of IKZF1, as well as rs2239633 in the locus of the 
CEBPE gene. When a hybrid statistical method (re-
sults shown in Table II) was used, statistical signif-
icance was more convincing than statistical anal-
ysis of separate association studies. The results 
of the family-based association study (TDT) are 
shown in Table III. The results of statistical analysis 
for case-control analysis are shown in Table IV. Sep-
arately analysing both designs showed the same 
results that the C allele of rs10821936 increases 
the risk of ALL, especially in a homozygous state.
Using the hybrid statistical method we also 
identified some risk-increasing combinations for 
Table I. Polymerase chain reaction primer sequences and restriction enzymes
Polymorphism Primer sequence Annealing  
temperature [°C]
Restriction enzyme
rs4132601 Forward: 5’-TCATGGATTTCTCTGCTCACA-3’ 59 MboI (Thermo Fisher Scientific, 
Waltham, MA, USA)
Reverse: 5’-TTCTGGTTTGAGCTTTGTTTGA-3’ 
rs2239633 Forward: 5’-GGGCTGGAAACGCACTAATA-3’ 60 Bsh1236I (Thermo Fisher 
Scientific, Waltham, MA, USA)
Reverse: 5’-CCACTCTGAGCAACCTCCTC-3’
rs3731217 Forward: 5’-CATGTAGATGGTGCCCCTGA-3’ 55 MvaI (Thermo Fisher Scientific, 
Waltham, MA, USA)
Reverse: 5’-CCCCTCTCAAATATGCTGTCC-3’
rs1800566 Forward: 5’-TGAGAAGCCCAGACCAACTT-3’ 60 HinfI (Thermo Fisher Scientific, 
Waltham, MA, USA)
Reverse: 5’-TCTCCAGGCGTTTCTTCCAT-3’
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previously described SNPs (SNP order in genotype: 
rs10821936, rs4132601, rs2239633, rs3731217 
and rs1800566); genotype CCTTCCTTCC was sta-
tistically significantly more frequently observed in 
affected children (p = 0.046). Similar results were 
obtained for genotypes CCGGCCTTCC (p = 0.049) 
and CCTTTTTTCC (p = 0.032).
The GSTT1 and GSTM1 null allele detection 
method has a limitation in that this method only 
detects the presence of the null genotype in a ho-
mozygous state. For statistical analysis we could 
only compare the frequency of the null genotype 
versus the non-null genotype. There was no sta-
tistically significant association between the risk 
of childhood acute leukaemia and polymorphisms 
of GSTM1 and GSTT1. The GSTT1 null variant was 
observed in 27.6% of cases and in 18% of controls 
Table II. Hybrid analysis of SNP alleles in family trios and case-controls
Polymorphism MAF Dose RR 95% CI P-value
rs10821936 C Single 1.3 (0.69–2.2) 0.44
Double 4.65 (2.03–10.6) 0.0006
rs4132601 G Single 1.03 (0.58–1.78) 0.92
Double 1.36 (0.54–3.3) 0.5
rs2239633 T Single 0.91 (0.52–1.63) 0.76
Double 0.74 (0.33–1.65) 0.47
rs3731217 G Single 0.77 (0.37–1.65) 0.5
Double – –
rs1800566 T Single 0.94 (0.53–1.66) 0.7
Double 0.57 (0.05–4.5) 0.33
Table III. Family-based association study TDT test
Polymorphism OR (95% CI) P-value
rs10821936 2.07 (1.07–4.03) 0.027
rs4132601 0.73 (0.4–1.32) 0.3
rs2239633 0.62 (0.35–1.12) 0.11
rs3731217 1 (0.32–3.1) 1
rs1800566 0.8 (0.38–1.67) 0.68
Table IV. Frequency of SNPs in the patient and control groups
Polymorphism Allele ALL cases Controls OR (95% CI) P-value
rs10821936 CC 14 (18.7%) 9 (7.5%) 2.83 (1.1–7.59) 0.02
CC + CT 38 (50.6%) 40 (33.3%) 1.49 (0.8–2.78) 0.19
C 52 (34.6%) 71 (29.6%) 1.67 (1.1–2.67) 0.028
rs4132601 GG 8 (10.6%) 7 (6.1%) 1.83 (0.56–5.9) 0.28
GG + GT 40 (53.3%) 51 (44.7%) 1.41 (0.75–2.65) 0.3
G 48 (32%) 58 (25.4%) 1.38 (0.85–2.23) 0.2
rs2239633 TT 13 (17.1%) 23 (19.1%) 0.87 (0.38–1.96) 0.85
TT + CT 51 (67.1%) 75 (62.5%) 0.84 (0.43–1.64) 0.63
T 64 (42.1%) 108 (45%) 0.89 (0.58–1.37) 0.6
rs3731217 GT 12 (16.2%) 26 (21.8%) 0.69 (0.3–1.56) 0.36
G 12 (8.1%) 26 (10.9%) 0.72 (0.33–1.55) 0.48
rs1800566 TT 1 (1.3%) 5 (4.1%) 0.31 (0.01–2.8) 0.41
TT + CT 22 (28.9%) 42 (30.6%) 0.82 (0.42–1.58) 0.54
T 2 10 0.78 (0.44–1.38) 0.42
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(p = 0.16, OR = 1.69, 95% CI: 0.8–3.53), and the 
GSTM null variant was observed in 55.8% of cas-
es and in 47.9% of controls (p = 0.3, OR = 1.37, 
95% CI: 0.74–2.54). 
Discussion
Acute lymphoblastic leukaemia is a multifacto-
rial disease influenced by genetic and environmen-
tal factors. In this study we investigated whether 
SNPs which were previously reported in GWAS 
studies influence the risk of ALL in the Latvian pop-
ulation. We chose the most studied cases, because 
Xu et al. hypothesized that the genetic predisposi-
tion to ALL might be largely mediated by the robust 
effects of a modest number of key genes, rather 
than the cumulative effect of tens of thousands of 
variants with small effects [31]. We also studied 
the influence of xenobiotic metabolism involved 
genes as a  possible risk factor. Although our co-
hort covered 89.4% of all patients, an important 
limitation of this study was the sample size. This 
may have influenced our ability to detect small as-
sociations. In this study we were able to replicate 
the results from previous studies, showing that 
rs10821936 increases the susceptibility to child-
hood ALL. As is shown in the literature, this SNP 
has a  strong association with childhood ALL [32, 
33]. In our study we used the hybrid method to 
improve statistical significance and join two de-
signs, and statistical analysis showed a  stronger 
association than the designs separately. Analysis 
of our data showed that individuals with genotype 
CC have a statistically significantly increased risk 
of development of ALL, whereas statistical signifi-
cance was lost if the individual was heterozygous. 
It is thought that gene variants have additive ef-
fects; someone inheriting one copy of a variant will 
have a roughly 50% increased risk, whereas some-
one who inherits all four variants in homozygous 
form would have a 10-fold increased risk [34]. 
In our study, rs4132601 in IKZF1 and rs2239633 
in CEBPE did not seem to affect the susceptibility 
to childhood ALL, although an association was 
found in previous GWAS studies [13] using data 
from Asian colleagues Wang et al. in the Chinese 
population, and Lin et al. in Taiwanese children. 
They have published data where these polymor-
phisms do not show any significant difference be-
tween cases and controls [11, 35]. Moreover, Wang 
et al. reported results of a cohort which consisted 
of 570 individuals, so small sample size could 
not be a  limitation of that study. Vijayakrishnan 
et al. reported on the racial differences between 
risk allele frequency in Asians and Caucasians 
[36]. As we belong to the European population 
our results should be similar to other European 
countries, but the only available published data 
are from Poland, Pastorczak et al., who only iden-
tified rs4132601 as a  possible risk variant, and 
they could not replicate the reported associations 
with rs2239633 or rs3731217, nor could we [37]. 
Our results could be explained by the limited sam-
ple size. Although we are located close to Poland 
geographically, our ethnic origin is not as closely 
related as shown in a  paper published by Nelis 
et al. [38]. To reach more reliable conclusions, 
further investigations closer to our gene pool are 
needed. However, Healy et al., from Canada, in 
a group of 284 childhood ALL patients, also were 
unable to replicate the reported associations with 
IKZF1 and CEBPE. Their group explained the lack of 
replication by the limited power of their study to 
detect loci with weaker effects [39]. In our study we 
were unable to find statistically significant differ-
ences between the GSTT1 and GSTM1 null variants 
and the risk of childhood ALL. As reported in the 
literature, based on a meta-analysis performed by 
Xu et al. including 2 424 cases, the GSTT1 null vari-
ant is strongly associated with the risk of childhood 
leukaemia in Asians, but there is no association in 
Caucasians [21]. Similar results about the GSTM1 
null variant were reported in a  meta-analysis by 
Tang et al., who found an overall association with 
ALL that was lost in Caucasians after stratification 
by ethnic groups [40], which might explain the lack 
of statistical significance in our study. Similarly, we 
could not find any association with another poly-
morphism involved in xenobiotic metabolism.
Although the meta-analysis performed by Han 
et al. showed an association with polymorphism 
609 C>T (rs1800566), especially in a  Caucasian 
population, they report that there is no associa-
tion between NQO1 polymorphism and childhood 
leukaemia [41]. These results showed a similari-
ty with ours, especially taking into consideration 
that only 18 out of 77 children in our ALL cohort 
were older than 10 at the time of the ALL diagno-
sis. We might hypothesize that our cohort was too 
young to observe the possible impact of polymor-
phisms involved in xenobiotic metabolism. 
In conclusion, overall, the ARID5B SNP 
rs10821936 has a significant association with the 
risk of childhood ALL – this polymorphism could 
serve as a  genetic susceptibility marker for ALL. 
The cohort should be enlarged to estimate the 
real effect of other SNPs, or if Estonian and Lith-
uanian samples could be available to validate the 
effect of these SNPs in neighbouring populations.
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